Clinical Trial Update: Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans [Phase 1]

View source ↗

Summary

Phase 1 study evaluating exendin(9-39)amide as a glucagon-like peptide-1 receptor antagonist in humans has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia

Drugs mentioned

• Exendin(9-39)amide (Exendin-9-39 amide)

Snippet

Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Hyperglycemia | Phase 1 | Status: COMPLETED